Detalhe da pesquisa
1.
RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell Apoptosis.
Cell Physiol Biochem
; 47(3): 1152-1166, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29913454
2.
Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).
Med Sci Monit
; 24: 2735-2743, 2018 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720580
3.
High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
BMC Cancer
; 16(1): 880, 2016 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836008
4.
Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.
Tumour Biol
; 36(11): 8797-803, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26058874
5.
The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization.
Tumour Biol
; 36(8): 6045-51, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25731733
6.
Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.
BMC Complement Altern Med
; 13: 89, 2013 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23622143
7.
Effect of the GLP-1 analog exendin-4 and oxaliplatin on intrahepatic cholangiocarcinoma cell line and mouse model.
Int J Mol Sci
; 14(12): 24293-304, 2013 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24351817
8.
[Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice].
Zhonghua Zhong Liu Za Zhi
; 35(11): 804-7, 2013 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-24447475
9.
[Anti-proliferation effect of sorafenib in combination with 5-FU for hepatocellular carcinoma in vitro: antagonistic performance and mechanism].
Zhonghua Gan Zang Bing Za Zhi
; 21(11): 845-9, 2013 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-24331695
10.
Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.
Evid Based Complement Alternat Med
; 2012: 908601, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23326293
11.
Psychophysiological restorative potential in cancer patients by virtual reality (VR)-based perception of natural environment.
Front Psychol
; 13: 1003497, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300069
12.
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
Cell Death Dis
; 9(5): 486, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706627
13.
Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
PLoS One
; 11(11): e0165681, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27814372
14.
Herbal Compound Songyou Yin and Moderate Swimming Suppress Growth and Metastasis of Liver Cancer by Enhancing Immune Function.
Integr Cancer Ther
; 15(3): 368-75, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26699805
15.
The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
Oncotarget
; 6(37): 40068-80, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517671
16.
CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
Oncol Rep
; 32(6): 2387-96, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242412
17.
Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1.
PLoS One
; 9(3): e89686, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24632571
18.
Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.
PLoS One
; 8(2): e55945, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23409093